Reece, Phillip Andrew <br/><br/>
Treatment options for H5N1: lessons learned from the H1N1 pandemic.  [electronic resource] 

 -  Postgraduate medicine  Sep 2010 
 - 134-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1941-9260 
<br/><br/><label>Standard No.: </label>10.3810/pgm.2010.09.2210  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acids, Carbocyclic<br/>Antiviral Agents--therapeutic use<br/>Cyclopentanes--therapeutic use<br/>Disease Outbreaks<br/>Drug Resistance, Viral<br/>Guanidines--therapeutic use<br/>Humans<br/>Immunocompromised Host<br/>Influenza A Virus, H5N1 Subtype<br/>Influenza, Human--drug therapy<br/>Oseltamivir--therapeutic use<br/>Pneumonia, Viral--drug therapy<br/>Pyrans<br/>Severity of Illness Index<br/>Sialic Acids<br/>Zanamivir--analogs & derivatives